CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY

被引：0
|
作者：
Janssens, A. [1 ]
Cervinek, L. [2 ]
Tejeda Romero, M. [3 ]
Wang, X. [4 ]
Eisen, M. [4 ]
机构：
[1] Univ Hosp Leuven, Dept Hematol, Campus Gasthuisberg, Leuven, Belgium
[2] Masaryk Univ, Univ Hosp, Brno, Czech Republic
[3] Hosp Juarez Mexico, Mexico City, DF, Mexico
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P03
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY
    Janssens, A.
    Cervinek, L.
    Tejeda Romero, M.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 138 - 139
  • [2] Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
    Kuter, David J.
    Mufti, Ghulam J.
    Bain, Barbara J.
    Hasserjian, Robert P.
    Davis, Wende
    Rutstein, Mark
    BLOOD, 2009, 114 (18) : 3748 - 3756
  • [3] Response of Refractory Immune Thrombocytopenia After Bone Marrow Transplantation to Romiplostim
    Beek, Jill C.
    Burke, Michael J.
    Tolar, Jakub
    PEDIATRIC BLOOD & CANCER, 2010, 54 (03) : 490 - 491
  • [4] Predictors of Remission in Adults with Immune Thrombocytopenia Treated with Romiplostim
    Newland, Adrian
    Bussel, James B.
    Bird, Robert
    Arnold, Donald M.
    Kessler, Craig M.
    Mayer, Jiri
    Romero, Monica Tejeda
    Janssens, Ann
    Wang, Kejia
    Eisen, Melissa Jeanne
    BLOOD, 2018, 132
  • [5] Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
    Ann Janssens
    Francesco Rodeghiero
    David Anderson
    Beng H. Chong
    Zoltán Boda
    Ingrid Pabinger
    Libor Červinek
    Deirdra R. Terrell
    Xuena Wang
    Janet Franklin
    Annals of Hematology, 2016, 95 : 1077 - 1087
  • [6] Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
    Janssens, Ann
    Rodeghiero, Francesco
    Anderson, David
    Chong, Beng H.
    Boda, Zoltan
    Pabinger, Ingrid
    Cervinek, Libor
    Terrell, Deirdra R.
    Wang, Xuena
    Franklin, Janet
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1077 - 1087
  • [7] PERSISTENT REMISSION OF CHRONIC IMMUNE THROMBOCYTOPENIA AFTER ROMIPLOSTIM DISCONTINUATION
    Biagiotti, C.
    Carrai, V.
    Alterini, R.
    Rigacci, L.
    Bosi, A.
    HAEMATOLOGICA, 2013, 98 : 737 - 737
  • [8] The development of romiplostim for patients with immune thrombocytopenia
    Molineux, Graham
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010, 2011, 1222 : 55 - 63
  • [9] Romiplostim Dose Response in Patients With Immune Thrombocytopenia
    Perez-Ruixo, J. J.
    Green, B.
    Doshi, S.
    Wang, Y. -M.
    Mould, D. R.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (10): : 1540 - 1551
  • [10] A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia
    Mahabir, Vishwanath K.
    Ross, Catherine
    Popovic, Snezana
    Sur, Mona Lisa
    Bourgeois, Jacqueline
    Lim, Wendy
    George, James N.
    Wang, Grace
    Cook, Richard J.
    Toltl, Lisa J.
    Nazi, Ishac
    Kelton, John G.
    Arnold, Donald M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (02) : 121 - 126
12345